The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients.
Shouval
Daniel
D
Liver Unit, Hadassah-Hebrew University, Jerusalem, Israel. shouval@hadassah.org.il
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004279:DNA, Viral / Q000187:drug effects / Q000502:physiology; D006509:Hepatitis B / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006511:Hepatitis B Antigens / Q000097:blood / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000187:drug effects; D006801:Humans; D007108:Immune Tolerance; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D012008:Recurrence
D000998:Antiviral Agents; D004279:DNA, Viral; D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines